Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Unknown 1Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 18Myeloid 3Thoracic 1Sarcoma 1Plasma cell 1Other solid neoplasm 1Lymphoid 1Gynecologic 1Genitourinary 1Gastrointestinal 1Dermatologic 1CNS 1

Conditions

Melanoma 312Carcinoma, Basal Cell 60Skin Neoplasms 52Lymphoma, T-Cell, Cutaneous 37Breast Neoplasms 31Uveal Melanoma 29Neoplasms 27Lung Neoplasms 27Carcinoma, Non-Small-Cell Lung 27Keratosis, Actinic 25Neoplasm Metastasis 24Carcinoma, Squamous Cell 22Carcinoma, Renal Cell 21Lymphoma 17Mycosis Fungoides 16Lymphoma, Large B-Cell, Diffuse 15Hodgkin Disease 15Urinary Bladder Neoplasms 14Sezary Syndrome 14Pancreatic Neoplasms 14Lymphoma, Non-Hodgkin 14Lymphoma, Follicular 14Leukemia, Lymphocytic, Chronic, B-Cell 14Precursor Cell Lymphoblastic Leukemia-Lymphoma 13Ovarian Neoplasms 13Lymphoma, Mantle-Cell 13Lymphoma, B-Cell, Marginal Zone 13Colorectal Neoplasms 13Burkitt Lymphoma 13Lymphoma, Large-Cell, Immunoblastic 12

Interventions

Immunotherapy, Adoptive 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Leukemia, Myeloid × Dermatologic × Clear all
NCT03638206 2019-12-11

Autologous CAR-T/TCR-T Cell Immunotherapy for Malignancies

Shenzhen BinDeBio Ltd.

Phase 1/2 Unknown
73 enrolled
CNSDermatologicGastrointestinalGenitourinaryGynecologicLymphoidOther hematologic neoplasmOther solid neoplasmPlasma cellSarcomaThoracic

Burkitt Lymphoma, Carcinoma, Renal Cell, Esophageal Neoplasms, Glioma, Carcinoma, Hepatocellular, Leukemia, Myeloid, Lung Neoplasms, Lymphoma, Melanoma, Mesothelioma, Multiple Myeloma, Ovarian Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms, Sarcoma, Synovial, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡